Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.
Clínica Alemana de Santiago, Vitacura, Santiago, Chile.
Transl Res. 2019 Oct;212:80-88. doi: 10.1016/j.trsl.2019.06.004. Epub 2019 Jul 4.
The aim of this study was to explore the relationship between serum soluble angiotensin converting enzyme 2 (sACE2), parameters of cardiopulmonary exercise testing and plasma asymmetric dimethylarginine (ADMA), a marker of oxidative stress-induced endothelial dysfunction. This has not been previously evaluated. We assessed 50 consecutive ambulatory patients with chronic systolic heart failure and left ventricular ejection fraction (LVEF) ≤45%. Their blood samples were collected for sACE2 and ADMA tests before they underwent symptom-limited cardiopulmonary exercise testing and transthoracic echocardiography. The majority of our study subjects had New York Heart Association functional class II (74%) and III (18%) presentation, and 42% of patients had ischemic etiology. Median sACE2 activity was 10.36 (7.00-14.47) ng/mL and mean ADMA was 0.90 ± 0.22. sACE2 activity was inversely correlated with pVO (r = -0.42, P = 0.00283), exercise time (r = -0.35, P = 0.0138) and LVEF (r = -0.548, P < 0.001), and positively correlated with VE/VCO slope (r = 0.294, P = 0.0405), ΔDBP (r = 0.315, P = 0.0278), mitral E/Ea ratio (r = 0.442, P = 0.00158) and ADMA levels (r = 0.351, P = 0.0134). Meanwhile, we observed a negative correlation between ADMA and pVO (r = -0.424, P = 0.00227) and positive correlations between ADMA and VE/VCO slope (r = 0.515, P < 0.001), ΔDBP (r = 0.391, P = 0.00568), mitral E/Ea ratio (r = 0.426, P = 0.00219). In multivariate logistic regression analysis, sACE2 was independently associated with peak oxygen uptake (% predicted) after adjusting for body mass index (BMI) and mitral E/Ea ratio (odds ratio [OR] 0.81 (0.58-0.94), P = 0.041) and associated with oxygen pulse (VO/HR) (%) after adjusting for age, gender, BMI and mitral E/Ea ratio (OR 0.83 [0.68-0.95], P = 0.025). Therefore in stable chronic systolic heart failure patients, higher sACE2 activity is independently associated with diminished exercise capacity and correlates with elevated systemic oxidative stress-mediated endothelial dysfunction.
本研究旨在探讨血清可溶性血管紧张素转换酶 2(sACE2)、心肺运动试验参数与血浆不对称二甲基精氨酸(ADMA)之间的关系,ADMA 是氧化应激诱导内皮功能障碍的标志物。这在以前的研究中尚未得到评估。我们评估了 50 例连续的慢性收缩性心力衰竭伴左心室射血分数(LVEF)≤45%的门诊患者。在进行症状限制心肺运动试验和经胸超声心动图检查之前,采集他们的血液样本进行 sACE2 和 ADMA 检测。我们的研究对象大多数为纽约心脏协会(NYHA)心功能 II 级(74%)和 III 级(18%),42%的患者存在缺血性病因。中位 sACE2 活性为 10.36(7.00-14.47)ng/mL,平均 ADMA 为 0.90±0.22。sACE2 活性与 pVO(r=-0.42,P=0.00283)、运动时间(r=-0.35,P=0.0138)和 LVEF(r=-0.548,P<0.001)呈负相关,与 VE/VCO 斜率(r=0.294,P=0.0405)、ΔDBP(r=0.315,P=0.0278)、二尖瓣 E/Ea 比值(r=0.442,P=0.00158)和 ADMA 水平(r=0.351,P=0.0134)呈正相关。同时,我们观察到 ADMA 与 pVO(r=-0.424,P=0.00227)呈负相关,与 VE/VCO 斜率(r=0.515,P<0.001)、ΔDBP(r=0.391,P=0.00568)、二尖瓣 E/Ea 比值(r=0.426,P=0.00219)呈正相关。多元逻辑回归分析表明,在调整体重指数(BMI)和二尖瓣 E/Ea 比值后,sACE2 与峰值摄氧量(%预测)独立相关(比值比[OR]0.81(0.58-0.94),P=0.041),与氧脉搏(VO/HR)(%)独立相关(OR 0.83(0.68-0.95),P=0.025)。因此,在稳定的慢性收缩性心力衰竭患者中,较高的 sACE2 活性与运动能力下降独立相关,并且与全身氧化应激诱导的内皮功能障碍升高相关。